Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10272034
Auris formulations for treating otic diseases and conditions
granted -
US 10265394
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted -
US 10266850
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10265372
Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues
granted -
US 10258645
Citrate containing beverage
granted -
US 10258629
Liposomal drug encapsulation
granted -
US 10259824
Complement C3d-binding compounds
granted -
US 10260101
C-kit oncogene mutations in melanoma
granted -
US 10259845
Peptides whose uptake by cells is controllable
granted -
US 10251778
Therapeutics dispensing device and methods of making same
granted -
US 10253039
Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria
granted -
US 10251977
Compositions and methods for tissue repair with extracellular matrices
granted -
US 10251894
Anticonvulsant activity of steroids
granted -
US 10245330
Compositions and methods for imaging
granted -
US 10245322
Nanostructured carriers for guided and targeted on-demand substance delivery
granted -
US 10246471
ETP derivatives
granted -
US 10240157
Diagnostic and screening methods for atopic dermatitis
granted -
US 10238750
Porphyrin modified telodendrimers
granted -
US 10238674
Bovine milk oligosaccharides
granted -
US 10238734
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted -
US 10239954
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer
granted -
US 10232044
Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
granted -
US 10232059
Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
granted -
US 10233240
Methods for treating cholestatic liver fibrosis
granted